Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. - Wikidata - wikimedia - TriplyDB

Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.

Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.

http://www.wikidata.org/entity/Q37378435

about

Uremic Toxins - Novel Arrhythmogenic Factor in Chronic Kidney Disease - Related Atrial Fibrillation Chronic Kidney Disease and Fibrosis: The Role of Uremic Retention Solutes The balance of powers: Redox regulation of fibrogenic pathways in kidney injury Cellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its Comorbidities Perspectives on systems biology applications in diabetic kidney disease Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy Management of the cardiorenal syndrome in decompensated heart failure Gut Bacteria and Hydrogen Sulfide: The New Old Players in Circulatory System Homeostasis Indoxyl Sulfate-Review of Toxicity and Therapeutic Strategies The microbiota and chronic kidney diseases: a double-edged sword Crosstalk between the unfolded protein response and NF-κB-mediated inflammation in the progression of chronic kidney disease Metabolomics and diabetes: analytical and computational approaches The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease Nrf2 protects against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced oxidative injury and steatohepatitis Untargeted plasma metabolite profiling reveals the broad systemic consequences of xanthine oxidoreductase inactivation in mice Indoxyl sulfate induces leukocyte-endothelial interactions through up-regulation of E-selectin Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate.Triggering of suicidal erythrocyte death by uremic toxin indoxyl sulfate.The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor.Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease.The Effect of Diet on the Survival of Patients with Chronic Kidney Disease.Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary study Timing of dialysis initiation in transplant-naive and failed transplant patients p-Cresol and cardiovascular risk in mild-to-moderate kidney disease The production of p-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores.Novel method for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: clinical data and pathophysiological implications.The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review.Uremic toxins induce kidney fibrosis by activating intrarenal renin-angiotensin-aldosterone system associated epithelial-to-mesenchymal transition.Podocyte injury caused by indoxyl sulfate, a uremic toxin and aryl-hydrocarbon receptor ligand.Analytical approaches to metabolomics and applications to systems biology Estimated glomerular filtration rate is a poor predictor of the concentration of middle molecular weight uremic solutes in chronic kidney disease Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress The Influence of Dietary Protein Intake on Mammalian Tryptophan and Phenolic Metabolites.p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease The colon: an overlooked site for therapeutics in dialysis patients.An update on uremic toxins.Decrease in irisin in patients with chronic kidney disease

P2860

Q26747869-EDBDC668-ABF6-4B9B-8D7F-B774F2D54EB1 Q26784008-04E22579-7B8F-4F3F-99C2-991CA90F06AF Q26786137-13C511F1-02BC-474C-9776-7604C618B92C Q26798487-0E132F68-00E8-490D-8113-578463F56C9B Q26823206-A42118D0-9F35-41BD-BBDF-D4BCC81B64A3 Q26859689-A344EF33-2954-4BFF-8DA9-31973325E94A Q27028203-D1B6D6CD-DEB7-4F8E-8F44-52735AD5A5BE Q28066350-7BBF0B90-1B9A-4D9E-B1B3-7CE7A46D8689 Q28075033-D8FD1A95-05B4-4A5F-899B-D14B6AC73D7C Q28078306-D3406B8F-915E-4E5E-A6BC-D1EC2E2E4088 Q28080433-B9AC17F4-B9AB-4B7E-AC8A-57A86200E030 Q28084835-F61B49E2-5D72-43BC-8833-EF591DC81172 Q28382992-7E7F5628-06FC-44CF-8EEF-A5BE3B3AC5F7 Q28392304-E7349FCE-29F6-475A-821C-971B5B2DC3D6 Q28480520-9FDF7D30-72F3-436F-A2A5-8F0D8341A33D Q30497600-4639145F-D855-41D9-81EC-DBBB7F321B82 Q31076633-415C1CDC-1DD9-4055-A39A-70137DE70571 Q31142636-5F060074-E277-4A05-A3C6-092D4746B875 Q33587787-59B90C6A-5550-4A91-B01F-294E387CC14E Q33613115-BC6950EF-397F-4615-AD65-D4F81845E79B Q33749467-08FD19C2-6D39-49AB-9E46-AA02844ECFAF Q33749490-1A60EC13-2E7E-485C-88BF-51AD723593E3 Q33793516-4A4D523E-9C1A-4450-AF24-188A6E843BC1 Q33919866-010CD192-8BF5-4358-99A7-8311D15C3BED Q33944858-8810E54F-35E3-4270-B8BF-0FF6807DECE5 Q34031430-1F6C981C-1832-4E3D-A076-376CFB185E92 Q34100425-D766CEAC-09F9-4B31-A315-6621E734FB83 Q34103477-B430FEE1-5786-454A-9162-C70A9E5F6F65 Q34221944-F4C6C0F9-9F88-4DCA-8F77-059F3C3E0CC2 Q34227115-BDA49BE1-2372-485E-A7D1-A777301B367D Q34340503-A7351E66-77AE-482B-87D3-4C890CFF4939 Q34406428-2FFCCE6B-73C3-4DDA-A044-4B0A10B2C592 Q34484986-CB7C2ADD-6259-4CA8-9E80-563E9559FA2F Q34497254-09D04DB3-D67E-4A69-A114-2D0D09B8A8D4 Q34498094-55B20468-53BD-4A56-8790-6BC03F433C5F Q34593224-8FB09650-7170-4044-A31E-EBE2C8B612B3 Q34595154-B091C62F-4A5C-47F0-A3D0-55CD3E2C6ECA Q34607428-37B7C800-F7A0-41C0-A81F-95A5D309C90E Q34641464-23946E7A-F832-4C98-AB05-9B87EDC1C4B2 Q34718513-7F9022FD-4E39-4079-927D-903CFA55C21C

P2860

Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.

http://www.wikidata.org/entity/Q37378435

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 August 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Serum indoxyl sulfate is assoc ...... ronic kidney disease patients.

@en

Serum indoxyl sulfate is assoc ...... ronic kidney disease patients.

@nl

type

label

Serum indoxyl sulfate is assoc ...... ronic kidney disease patients.

@en

Serum indoxyl sulfate is assoc ...... ronic kidney disease patients.

@nl

prefLabel

Serum indoxyl sulfate is assoc ...... ronic kidney disease patients.

@en

Serum indoxyl sulfate is assoc ...... ronic kidney disease patients.

@nl

P1433

Q37378435-2CA56D1C-C663-4B73-9D19-38147A86DB75

P1476

Q37378435-A0617BF7-6ACA-4776-A382-B439E93B0157

P2093

Q37378435-01B0443A-4B6B-473C-9AE5-FB2C9E8D3507

Q37378435-2B157587-AF9E-4B3C-8049-67EF190FB3A8

Q37378435-469978B1-5855-4A03-B9C5-F16DA543D4B6

Q37378435-48A31B9A-D4AC-4938-B4CD-8AC9D18AB0F2

Q37378435-59F594BF-04E2-44B1-AA7B-2E13B2E9911D

Q37378435-5D3727F3-CE17-4BBC-8F30-87E5135E617F

Q37378435-7B1DDACC-F1BA-46A9-946D-311B5986AF63

Q37378435-98EAA506-9C99-457A-AF6A-395813F4B467

Q37378435-A986441D-682A-420F-BC76-A97FF46B1139

P2860

Q37378435-0C5A99CF-9273-4A30-A99B-DEBB3AEB11D3

Q37378435-172EE01F-E553-4C6A-8464-7D30B8D8168A

Q37378435-1989272F-8E95-4954-8804-0652605822BD

Q37378435-20C5F70E-715C-4A5B-B29C-BEB76001F06A

Q37378435-23039A4D-97BD-4051-AC71-9274A760ECBC

Q37378435-2AD95803-CFC6-487D-AE7A-E1AEFC8FF510

Q37378435-5E9E6A76-4AA9-44F9-878B-11C69B644600

Q37378435-6E82E412-1895-49F8-8F6D-6927449086F4

Q37378435-741E9CAA-D3AF-412D-96BB-7B3D69643A43

Q37378435-78375837-6375-4CA9-845E-AAD4911A3725

P304

Q37378435-6DC80FE3-5E6F-4FCC-9CEF-69D8F9F48428

P31

Q37378435-4C0FE095-9FEB-481F-B4A4-89DE4955ACF9

P356

Q37378435-BC2216D8-FC3D-4D27-B4FE-B1A436966337

P433

Q37378435-BF755572-66B6-4CBE-A07E-4DBF3D1B069B

P478

Q37378435-6B275DAA-39E2-4545-B0FF-3101F0239BC9

P50

Q37378435-118C7FA0-662F-4C5C-8CF1-F9752099A014

P577

Q37378435-E07EFD98-904D-49CC-884D-2C03FC059BA5

P5875

Q37378435-17298C56-1D32-4470-BF92-22071BF5CF95

P698

Q37378435-B3FDCE4E-9B63-44D7-BABC-04E8CB6AC38D

P921

Q37378435-86B82DC5-1CA9-4D3F-BD46-0C0AA46904A0

P932

Q37378435-E6E25304-C7AA-476F-9FCD-57DC010DBFF9

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Serum indoxyl sulfate is assoc ...... ronic kidney disease patients.

@en

P2093

Daniela V Barreto

http://www.w3.org/2001/XMLSchema#string

European Uremic Toxin Work Group (EUTox)

http://www.w3.org/2001/XMLSchema#string

Fellype C Barreto

http://www.w3.org/2001/XMLSchema#string

Gabriel Choukroun

http://www.w3.org/2001/XMLSchema#string

Griet Glorieux

http://www.w3.org/2001/XMLSchema#string

Mohammed Temmar

http://www.w3.org/2001/XMLSchema#string

Natalie Meert

http://www.w3.org/2001/XMLSchema#string

Sophie Liabeuf

http://www.w3.org/2001/XMLSchema#string

Ziad A Massy

http://www.w3.org/2001/XMLSchema#string

P2860

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

Prediction of creatinine clearance from serum creatinine

Cardiovascular disease in chronic renal insufficiency.

Chronic kidney disease as cause of cardiovascular morbidity and mortality.

A bench to bedside view of uremic toxins.

Vitamin D affects survival independently of vascular calcification in chronic kidney disease.

Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity.

Uraemic toxins induce proximal tubular injury via organic anion transporter 1-mediated uptake.

Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress.

P304

1551-1558

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.03980609

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Raymond Vanholder

P577

2009-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26756690

http://www.w3.org/2001/XMLSchema#string

P698

19696217

http://www.w3.org/2001/XMLSchema#string

P921

P932

2758258

http://www.w3.org/2001/XMLSchema#string